NEJM Interviews

NEJM Interview: Dr. William Feldman on a new federal price-transparency rule and legal challenges to efforts to increase access to pricing information.

02.10.2021 - By NEJM GroupPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Dr. William Feldman is a physician and researcher in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. W.B. Feldman and Others. The Future of Drug-Pricing Transparency. N Engl J Med 2021;384:489-491.

More episodes from NEJM Interviews